Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03794466 · ClinicalTrials.gov registry record

Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization

A clinical trial of Pelvic Pain and Pelvic Congestive Syndrome, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
30
Enrollment target
1
Study location

NCT03794466 is a study of Pelvic Pain and Pelvic Congestive Syndrome that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 30 participants, below the 370-participant average among 23 other Pelvic Pain trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03794466, a study of Pelvic Pain and Pelvic Congestive Syndrome, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.

Study Locations (1)

Kansas

  • The University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2019-05-10
Est. Completion 2027-12-31

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT03794466

The ClinicalTrials.gov registry entry for NCT03794466 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 370-participant average among 23 other Pelvic Pain trials with a reported enrollment target (92% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pelvic Pain appearing as the primary indexed condition, and to 0 interventions.

NCT03794466 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT03794466 about?

NCT03794466 is a clinical study titled "Quantify the Degree of Pain Relief of Pelvic Congestion Syndrome Following Gonadal Vein Embolization". The primary objective is to quantify the degree of pain relief in patients undergoing gonadal vein embolization with coils as well as identify clinical or imaging factors that are predictive of a positive response to treatment, or poor response to treatment.

What is the current status of trial NCT03794466?

This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2019-05-10. Estimated completion is 2027-12-31.

What conditions does trial NCT03794466 study?

This clinical trial studies the following conditions: Pelvic Pain, Pelvic Congestive Syndrome.

Who is sponsoring clinical trial NCT03794466?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03794466 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.